Back

Abingworth Exceeds Target on Latest Life-Sciences Fund

  • Written By: Asante Capital

U.K. life-sciences investor Abingworth said it has closed a new fund with $315 million. The vehicle, Abingworth Bioventures VII LP, exceeded its $300 million target. Placement agent Asante Capital Group helped raise the fund. Abingworth has invested in more than 145 life-sciences companies and raised 12 life-sciences funds since its founding in 1973.

READ FULL ARTICLE ON WSJ PRO

Artá Capital races to first close with commitments of €305m on a target of €400m

We are pleased to announce that Artá Capital Partners (“Artá”), a leading Iberian private equity firm, has raised over three quarters of their €400m target at the first close of Artá Capital Fund III LP (“Fund III”).

Winner at Private Equity Wire Awards 2023

We are honoured to be named Best Placement Agent as part of Private Equity Wire’s European Awards 2023! Winners were selected based on performance data and industry voting.

Asante Capital Solutions – Q4 2022 Newsletter

Following a decade of robust and unprecedented growth in the Asia-Pacific private equity region, 2022 brought with it a combination of challenges, ranging from the lingering effects of the COVID pandemic, global economic downturn and general macro uncertainty, casting a dark cloud over the region’s private markets. The answer to what the market in 2023 will look like is multi-faceted: in this newsletter, we are putting a spotlight on the key trends we are seeing in the APAC region and assessing their impact on the fundraising landscape.
Back to top
© Asante 2023
Design by Firedog